2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Soliris: new trials by email Literature Review of Soliris trials Research Report on Soliris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation Eculizumab - Kidney Transplant | Phase 1 / Phase 2 | Terminated | Mayo Clinic | 6 | 2010-05-01 | 2015-07-20 |
| Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant Eculizumab - Kidney Transplant | Phase 1 / Phase 2 | Terminated | Mayo Clinic | 2 | 2010-03-01 | 2018-01-31 |
Mayo Clinic (2)
United States (2)
Mark D Stegall (1) · Mark Stegall, MD (1)
UL1TR000135 (1)